Quad Technologies, a provider of cell and gene therapy bioprocessing reagents, has opened a new, larger headquarters and laboratory in order to expand manufacturing capabilities and offer clients quality reagents for gene-modified cell therapy bioprocesses.  “We are delivering a service and product that no other company currently offers: a unique T-cell activation reagent using patented QuickGel that ensures optimal efficiency and effectiveness. By moving into this larger office and labor...